SPECC1L-ADORA2A

Chr 22

SPECC1L-ADORA2A readthrough (NMD candidate)

This locus represents naturally occurring readthrough transcription between the neighboring SPECC1L (sperm antigen with calponin homology and coiled-coil domains 1-like) and ADORA2A (adenosine A2a receptor) genes on chromosome 22. The readthrough transcript is a candidate for nonsense-mediated mRNA decay (NMD) and is unlikely to produce a protein product. [provided by RefSeq, Jun 2013]

509
ClinVar variants
24
Pathogenic / LP
pLI score
0
Active trials
Clinical SummarySPECC1L-ADORA2A
📋
ClinVar Variants
24 Pathogenic / Likely Pathogenic· 306 VUS of 509 total submissions

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

509 submitted variants in ClinVar

Classification Summary

Pathogenic15
Likely Pathogenic9
VUS306
Likely Benign114
Benign43
Conflicting22
15
Pathogenic
9
Likely Pathogenic
306
VUS
114
Likely Benign
43
Benign
22
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
7
8
0
15
Likely Pathogenic
0
6
3
0
9
VUS
10
246
49
1
306
Likely Benign
0
36
23
55
114
Benign
0
12
17
14
43
Conflicting
22
Total1030710070509

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SPECC1L-ADORA2A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype

No OMIM entries found.

Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Top 10 resultsSearch PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →